Cardiovascular Devices Market by Device (Diagnostic and Monitoring Devices, Therapeutic and Surgical Devices, and Others), Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease, and Others), End-User (Hospitals, Ambulatory Surgical Centers and Cardiac Centers) and Geography – Global Forecast to 2027
Cardiovascular devices are adopted to diagnose and treat several heart diseases along with associated heart problems. Cardiovascular diseases or CVDs have been determined as the critical pain points of the medical industry. The key reason for mortality and disability worldwide is stroke or IHD (ischemic heart disease). Cardiovascular devices and their prominence in heart-related therapies are rapidly being brought into the limelight. The Cardiovascular Devices Market is likely to grow at the rate of 16.6% CAGR by 2027. Escalating demand and awareness on minimally invasive surgeries will propel market growth in the coming years. The key factors which drive the patient preference for minimally invasive procedures are advantages such as reduced risk of infection, small incisions, and relatively less time-consuming. The market is projected to obtain significant growth over the forecast period with the continuous technological developments towards miniaturization, material biocompatibility of implantable, and advanced navigation devices. Further, the increased risk related to cardiac procedures is likely to hamper the cardiovascular devices market growth.
Cardiovascular Devices Market based on Device
As per the market by application, cardiovascular devices are majorly applicable in coronary heart disease, a segment to hold a largest share in the market. This is due to the presence of the devices that include coronary stents used to treat coronary heart disease, which includes the narrowing of the arteries and may result in other cardiac conditions such as heart attacks.
Further, based on end-users, the prominent end-users having a major role in the market growth are hospitals. This is due to the increasing requirement for trained medical professionals to install vital cardiovascular devices such as stents. In addition, the hospitals are considered to provide medical procedures such as installing stents with minimum adverse reactions in patients.
As per the geographical analysis, North America accounted to acquire a substantial share of the market. The substantial share is ascribed to the key manufacturer’s presence in the region, high incidence of cardiovascular diseases, and Canada, the major factor for the expansion of the market.
Cardiovascular diseases (CVDs) are probable to remain the major cause of morbidity and mortality worldwide. The CVDs are the heart and blood vessels' disorders and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Therefore, some of the key lifestyle factors that result in cardiovascular disease and difficulties are unhealthy diet, tobacco, and physical inactivity, which increases the risk of heart attacks and strokes. Thus, the above factor is stimulating the global cardiovascular devices market growth.
Few notable vendors of the cardiovascular devices market are Medtronic, Boston, B. Braun Melsungen AG, Becton, Dickinson and Company, General Electric Company, Biosense Webster, Inc (Johnson and Johnson), Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V, Siemens AG, and Edwards Lifesciences Corporation.
Henceforth, cardiovascular devices are having a prominent role in the rising number of cardiovascular diseases scenario. Cardiovascular diseases have become most common among individuals, and cardiovascular devices have many benefits, including minimally invasive devices.
Cardiovascular Devices Market based on Device
- Diagnostic and Monitoring Devices
- Therapeutic and Surgical Devices
- Others
- Coronary Heart Disease
- Sudden Cardiac Arrest
- Stroke
- Cerebrovascular Heart Disease
- Others
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- North America
- Europe
- Asia Pacific
- Rest of the World
As per the market by application, cardiovascular devices are majorly applicable in coronary heart disease, a segment to hold a largest share in the market. This is due to the presence of the devices that include coronary stents used to treat coronary heart disease, which includes the narrowing of the arteries and may result in other cardiac conditions such as heart attacks.
Further, based on end-users, the prominent end-users having a major role in the market growth are hospitals. This is due to the increasing requirement for trained medical professionals to install vital cardiovascular devices such as stents. In addition, the hospitals are considered to provide medical procedures such as installing stents with minimum adverse reactions in patients.
As per the geographical analysis, North America accounted to acquire a substantial share of the market. The substantial share is ascribed to the key manufacturer’s presence in the region, high incidence of cardiovascular diseases, and Canada, the major factor for the expansion of the market.
Cardiovascular diseases (CVDs) are probable to remain the major cause of morbidity and mortality worldwide. The CVDs are the heart and blood vessels' disorders and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions. Therefore, some of the key lifestyle factors that result in cardiovascular disease and difficulties are unhealthy diet, tobacco, and physical inactivity, which increases the risk of heart attacks and strokes. Thus, the above factor is stimulating the global cardiovascular devices market growth.
Few notable vendors of the cardiovascular devices market are Medtronic, Boston, B. Braun Melsungen AG, Becton, Dickinson and Company, General Electric Company, Biosense Webster, Inc (Johnson and Johnson), Scientific Corporation, Abbott Laboratories, Koninklijke Philips N.V, Siemens AG, and Edwards Lifesciences Corporation.
Henceforth, cardiovascular devices are having a prominent role in the rising number of cardiovascular diseases scenario. Cardiovascular diseases have become most common among individuals, and cardiovascular devices have many benefits, including minimally invasive devices.
- Several factors are included in the study, which is impacting the market growth and restricting the market.
- This report consists of the segmentation and sub-segmentations and the segment’s contribution to the market growth.
- The report also includes the profiles of the key vendors in the market and their strategies, such as product launches, company expansions, and acquisitions.
- Further, the report depicts the penetration of the market in the various regions.
1. EXECUTIVE SUMMARY
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. DEVICE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Diagnostic and Monitoring Devices
5.3. Therapeutic and Surgical Devices
5.4. Others
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Coronary Heart Disease
6.3. Sudden Cardiac Arrest
6.4. Stroke
6.5. Cerebrovascular Heart Disease
6.6. Others
7. END-USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Cardiac Centers
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. Medtronic, Boston
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. B. Braun Melsungen AG
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Becton, Dickinson and Company
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. General Electric Company
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Biosense Webster, Inc (Johnson and Johnson)
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Scientific Corporation
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Abbott Laboratories
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Koninklijke Philips N.V
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Siemens AG
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Edwards Lifesciences Corporation
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
2. INDUSTRY OUTLOOK
2.1. Industry Overview
2.2. Industry Trends
3. MARKET SNAPSHOT
3.1. Market Definition
3.2. Market Outlook
3.2.1. Porter Five Forces
3.3. Related Markets
4. MARKET CHARACTERISTICS
4.1. Market Overview
4.2. Market Segmentation
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. DRO - Impact Analysis
5. DEVICE: MARKET SIZE & ANALYSIS
5.1. Overview
5.2. Diagnostic and Monitoring Devices
5.3. Therapeutic and Surgical Devices
5.4. Others
6. APPLICATION: MARKET SIZE & ANALYSIS
6.1. Overview
6.2. Coronary Heart Disease
6.3. Sudden Cardiac Arrest
6.4. Stroke
6.5. Cerebrovascular Heart Disease
6.6. Others
7. END-USER: MARKET SIZE & ANALYSIS
7.1. Overview
7.2. Hospitals
7.3. Ambulatory Surgical Centers
7.4. Cardiac Centers
8. GEOGRAPHY: MARKET SIZE & ANALYSIS
8.1. Overview
8.2. North America
8.3. Europe
8.4. Asia Pacific
8.5. Rest of the World
9. COMPETITIVE LANDSCAPE
9.1. Competitor Comparison Analysis
9.2. Market Developments
9.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
9.2.2. Product Launches and execution
10. VENDOR PROFILES
10.1. Medtronic, Boston
10.1.1. Overview
10.1.2. Financial Overview
10.1.3. Product Offerings
10.1.4. Developments
10.1.5. Business Strategy
10.2. B. Braun Melsungen AG
10.2.1. Overview
10.2.2. Financial Overview
10.2.3. Product Offerings
10.2.4. Developments
10.2.5. Business Strategy
10.3. Becton, Dickinson and Company
10.3.1. Overview
10.3.2. Financial Overview
10.3.3. Product Offerings
10.3.4. Developments
10.3.5. Business Strategy
10.4. General Electric Company
10.4.1. Overview
10.4.2. Financial Overview
10.4.3. Product Offerings
10.4.4. Developments
10.4.5. Business Strategy
10.5. Biosense Webster, Inc (Johnson and Johnson)
10.5.1. Overview
10.5.2. Financial Overview
10.5.3. Product Offerings
10.5.4. Developments
10.5.5. Business Strategy
10.6. Scientific Corporation
10.6.1. Overview
10.6.2. Financial Overview
10.6.3. Product Offerings
10.6.4. Developments
10.6.5. Business Strategy
10.7. Abbott Laboratories
10.7.1. Overview
10.7.2. Financial Overview
10.7.3. Product Offerings
10.7.4. Developments
10.7.5. Business Strategy
10.8. Koninklijke Philips N.V
10.8.1. Overview
10.8.2. Financial Overview
10.8.3. Product Offerings
10.8.4. Developments
10.8.5. Business Strategy
10.9. Siemens AG
10.9.1. Overview
10.9.2. Financial Overview
10.9.3. Product Offerings
10.9.4. Developments
10.9.5. Business Strategy
10.10. Edwards Lifesciences Corporation
10.10.1. Overview
10.10.2. Financial Overview
10.10.3. Product Offerings
10.10.4. Developments
10.10.5. Business Strategy
11. ANALYST OPINION
12. ANNEXURE
12.1. Report Scope
12.2. Market Definitions
12.3. Research Methodology
12.3.1. Data Collation and In-house Estimation
12.3.2. Market Triangulation
12.3.3. Forecasting
12.4. Report Assumptions
12.5. Declarations
12.6. Stakeholders
12.7. Abbreviations
LIST OF TABLES
TABLE 1. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR DIAGNOSTIC AND MONITORING DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR THERAPEUTIC AND SURGICAL DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CORONARY HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR SUDDEN CARDIAC ARREST, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR STROKE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CEREBROVASCULAR HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR AMBULATORY SURGICAL CENTRES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CARDIAC CENTERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 19. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 20. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 21. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 22. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 23. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 24. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 25. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 26. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 27. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 28. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, END-USER, 2021-2027 (USD BILLION)
TABLE 29. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 30. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 31. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 32. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 33. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 34. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 35. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 36. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 37. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 38. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 39. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 40. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 41. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 42. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 43. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 44. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 45. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 46. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 49. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 50. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 51. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 52. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 53. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 54. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 55. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 56. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 57. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 58. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 59. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 61. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 62. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 64. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 65. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 66. MEDTRONIC, BOSTON: FINANCIALS
TABLE 67. MEDTRONIC, BOSTON: PRODUCTS & SERVICES
TABLE 68. MEDTRONIC, BOSTON: RECENT DEVELOPMENTS
TABLE 69. B. BRAUN MELSUNGEN AG: FINANCIALS
TABLE 70. B. BRAUN MELSUNGEN AG: PRODUCTS & SERVICES
TABLE 71. B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
TABLE 72. BECTON, DICKINSON AND COMPANY: FINANCIALS
TABLE 73. BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES
TABLE 74. BECTON, DICKINSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 75. GENERAL ELECTRIC COMPANY: FINANCIALS
TABLE 76. GENERAL ELECTRIC COMPANY: PRODUCTS & SERVICES
TABLE 77. GENERAL ELECTRIC COMPANY: RECENT DEVELOPMENTS
TABLE 78. BIOSENSE WEBSTER, INC (JOHNSON AND JOHNSON): FINANCIALS
TABLE 79. BIOSENSE WEBSTER, INC (JOHNSON AND JOHNSON): PRODUCTS & SERVICES
TABLE 80. BIOSENSE WEBSTER, INC (JOHNSON AND JOHNSON): RECENT DEVELOPMENTS
TABLE 81. SCIENTIFIC CORPORATION: FINANCIALS
TABLE 82. SCIENTIFIC CORPORATION: PRODUCTS & SERVICES
TABLE 83. SCIENTIFIC CORPORATION: RECENT DEVELOPMENTS
TABLE 84. ABBOTT LABORATORIES: FINANCIALS
TABLE 85. ABBOTT LABORATORIES: PRODUCTS & SERVICES
TABLE 86. ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 87. KONINKLIJKE PHILIPS N.V: FINANCIALS
TABLE 88. KONINKLIJKE PHILIPS N.V: PRODUCTS & SERVICES
TABLE 89. KONINKLIJKE PHILIPS N.V: RECENT DEVELOPMENTS
TABLE 90. SIEMENS AG: FINANCIALS
TABLE 91. SIEMENS AG: PRODUCTS & SERVICES
TABLE 92. SIEMENS AG: RECENT DEVELOPMENTS
TABLE 93. EDWARDS LIFESCIENCES CORPORATION: FINANCIALS
TABLE 94. EDWARDS LIFESCIENCES CORPORATION: PRODUCTS & SERVICES
TABLE 95. EDWARDS LIFESCIENCES CORPORATION: RECENT DEVELOPMENTS
TABLE 1. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 2. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR DIAGNOSTIC AND MONITORING DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR THERAPEUTIC AND SURGICAL DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CORONARY HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR SUDDEN CARDIAC ARREST, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR STROKE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CEREBROVASCULAR HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR AMBULATORY SURGICAL CENTRES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CARDIAC CENTERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
TABLE 15. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 16. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 17. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 18. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 19. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 20. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 21. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 22. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 23. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 24. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 25. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 26. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 27. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 28. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, END-USER, 2021-2027 (USD BILLION)
TABLE 29. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 30. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 31. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 32. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 33. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 34. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 35. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 36. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 37. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 38. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 39. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 40. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 41. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 42. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 43. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 44. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 45. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 46. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 47. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
TABLE 48. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 49. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 50. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 51. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 52. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 53. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 54. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 55. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 56. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 57. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 58. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 59. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 60. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 61. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 62. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 63. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
TABLE 64. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
TABLE 65. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
TABLE 66. MEDTRONIC, BOSTON: FINANCIALS
TABLE 67. MEDTRONIC, BOSTON: PRODUCTS & SERVICES
TABLE 68. MEDTRONIC, BOSTON: RECENT DEVELOPMENTS
TABLE 69. B. BRAUN MELSUNGEN AG: FINANCIALS
TABLE 70. B. BRAUN MELSUNGEN AG: PRODUCTS & SERVICES
TABLE 71. B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
TABLE 72. BECTON, DICKINSON AND COMPANY: FINANCIALS
TABLE 73. BECTON, DICKINSON AND COMPANY: PRODUCTS & SERVICES
TABLE 74. BECTON, DICKINSON AND COMPANY: RECENT DEVELOPMENTS
TABLE 75. GENERAL ELECTRIC COMPANY: FINANCIALS
TABLE 76. GENERAL ELECTRIC COMPANY: PRODUCTS & SERVICES
TABLE 77. GENERAL ELECTRIC COMPANY: RECENT DEVELOPMENTS
TABLE 78. BIOSENSE WEBSTER, INC (JOHNSON AND JOHNSON): FINANCIALS
TABLE 79. BIOSENSE WEBSTER, INC (JOHNSON AND JOHNSON): PRODUCTS & SERVICES
TABLE 80. BIOSENSE WEBSTER, INC (JOHNSON AND JOHNSON): RECENT DEVELOPMENTS
TABLE 81. SCIENTIFIC CORPORATION: FINANCIALS
TABLE 82. SCIENTIFIC CORPORATION: PRODUCTS & SERVICES
TABLE 83. SCIENTIFIC CORPORATION: RECENT DEVELOPMENTS
TABLE 84. ABBOTT LABORATORIES: FINANCIALS
TABLE 85. ABBOTT LABORATORIES: PRODUCTS & SERVICES
TABLE 86. ABBOTT LABORATORIES: RECENT DEVELOPMENTS
TABLE 87. KONINKLIJKE PHILIPS N.V: FINANCIALS
TABLE 88. KONINKLIJKE PHILIPS N.V: PRODUCTS & SERVICES
TABLE 89. KONINKLIJKE PHILIPS N.V: RECENT DEVELOPMENTS
TABLE 90. SIEMENS AG: FINANCIALS
TABLE 91. SIEMENS AG: PRODUCTS & SERVICES
TABLE 92. SIEMENS AG: RECENT DEVELOPMENTS
TABLE 93. EDWARDS LIFESCIENCES CORPORATION: FINANCIALS
TABLE 94. EDWARDS LIFESCIENCES CORPORATION: PRODUCTS & SERVICES
TABLE 95. EDWARDS LIFESCIENCES CORPORATION: RECENT DEVELOPMENTS
LIST OF FIGURES
CHART. 1. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 2. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR DIAGNOSTIC AND MONITORING DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 3. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR THERAPEUTIC AND SURGICAL DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 4. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 5. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 6. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CORONARY HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 7. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR SUDDEN CARDIAC ARREST, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 8. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR STROKE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 9. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CEREBROVASCULAR HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 10. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 11. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 12. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 13. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR AMBULATORY SURGICAL CENTRES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 14. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CARDIAC CENTERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 15. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 16. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 17. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 18. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 19. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 20. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 21. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 22. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 23. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 24. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 25. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 26. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 27. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 28. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, END-USER, 2021-2027 (USD BILLION)
CHART. 29. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 30. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 31. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 32. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 33. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 34. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 35. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 36. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 37. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 38. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 39. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 40. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 41. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 42. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 43. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 44. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 45. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 46. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 47. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 48. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 49. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 50. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 51. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 52. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 53. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 54. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 55. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 56. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 57. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 58. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 59. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 60. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 61. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 62. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 63. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 64. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 65. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 1. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 2. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR DIAGNOSTIC AND MONITORING DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 3. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR THERAPEUTIC AND SURGICAL DEVICES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 4. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 5. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 6. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CORONARY HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 7. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR SUDDEN CARDIAC ARREST, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 8. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR STROKE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 9. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CEREBROVASCULAR HEART DISEASE, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 10. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR OTHERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 11. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 12. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR HOSPITALS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 13. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR AMBULATORY SURGICAL CENTRES, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 14. GLOBAL CARDIOVASCULAR DEVICES MARKET VALUE FOR CARDIAC CENTERS, BY GEOGRAPHY, 2021-2027 (USD BILLION)
CHART. 15. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 16. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 17. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 18. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 19. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 20. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 21. U.S CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 22. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 23. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 24. CANADA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 25. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 26. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 27. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 28. EUROPE CARDIOVASCULAR DEVICES MARKET VALUE, END-USER, 2021-2027 (USD BILLION)
CHART. 29. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 30. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 31. GERMANY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 32. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 33. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 34. U.K CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 35. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 36. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 37. FRANCE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 38. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 39. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 40. ITALY CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 41. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 42. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 43. SPAIN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 44. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 45. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 46. ROE CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 47. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY COUNTRY, 2021-2027 (USD BILLION)
CHART. 48. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 49. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 50. ASIA PACIFIC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 51. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 52. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 53. CHINA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 54. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 55. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 56. INDIA CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 57. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 58. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 59. JAPAN CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 60. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 61. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 62. REST OF APAC CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
CHART. 63. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY DEVICE, 2021-2027 (USD BILLION)
CHART. 64. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY APPLICATION, 2021-2027 (USD BILLION)
CHART. 65. REST OF WORLD CARDIOVASCULAR DEVICES MARKET VALUE, BY END-USER, 2021-2027 (USD BILLION)
